Invited Commentary: Human Papillomavirus Infection and Risk of Cervical Precancer—Using the Right Methods to Answer the Right Questions

Por Franco, Eduardo L., Tota, Joseph
Publicado em 2010

Optimizing technology for cervical cancer screening in high-resource settings

Por Richardson, Lyndsay A, Tota, Joseph, Franco, Eduardo L
Publicado no Expert Rev Obstet Gynecol (2011)

Cervical human papillomavirus detection is not affected by menstrual phase

Por Tota, Joseph E, Ramanakumar, Agnihotram V, Mahmud, Salaheddin M, Trevisan, Andrea, Villa, Luisa L, Franco, Eduardo L
Publicado no Sex Transm Infect (2012)

Guillain–Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States

Por Ojha, Rohit P, Jackson, Bradford E, Tota, Joseph E, Offutt-Powell, Tabatha N, Singh, Karan P, Bae, Sejong
Publicado em 2014

Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections

Por Tota, Joseph E., Ramanakumar, Agnihotram V., Villa, Luisa L., Richardson, Harriet, Burchell, Ann N., Coutlée, François, Franco, Eduardo L.
Publicado no J Infect Dis (2016)

Trends in cervical cancer incidence in younger US women from 2000-2013

Por Beachler, Daniel C., Tota, Joseph E., Silver, Michelle I., Kreimer, Aimée R., Hildesheim, Allan, Wentzensen, Nicolas, Schiffman, Mark, Shiels, Meredith S.
Publicado no Gynecol Oncol (2016)

Inequalities in vaccination coverage for young females whose parents are informal caregivers

Por Offutt-Powell, Tabatha N, Ojha, Rohit P, Brinkman, Tara M, Tota, Joseph E, Jackson, Bradford E, Singh, Karan P, Smith, Jennifer S
Publicado no Hum Vaccin Immunother (2014)

Human Papillomavirus-Associated Subsequent Malignancies among Long-Term Survivors of Pediatric and Young Adult Cancers

Por Ojha, Rohit P., Tota, Joseph E., Offutt-Powell, Tabatha N., Klosky, James L., Minniear, Timothy D., Jackson, Bradford E., Gurney, James G.
Publicado em 2013

Epidemiologic Approaches to Evaluating the Potential for Human Papillomavirus Type Replacement Postvaccination

Por Tota, Joseph E., Ramanakumar, Agnihotram V., Jiang, Mengzhu, Dillner, Joakim, Walter, Stephen D., Kaufman, Jay S., Coutlée, François, Villa, Luisa L., Franco, Eduardo L.
Publicado em 2013

Evaluation of Human Papillomavirus Type Replacement Post-vaccination Must Account for Diagnostic Artifacts: Masking of HPV52 by HPV16 in Anogenital Specimens

Por Tota, Joseph E., Ramanakumar, Agnihotram V., Villa, Luisa L., Richardson, Harriet, Burchell, Ann N., Koushik, Anita, Mayrand, Marie-Hélène, Coutlée, François, Franco, Eduardo L.
Publicado no Cancer Epidemiol Biomarkers Prev (2014)

Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination

Por Tota, Joseph E., Jiang, Mengzhu, Ramanakumar, Agnihotram V., Walter, Stephen D., Kaufman, Jay S., Coutlée, François, Richardson, Harriet, Burchell, Ann N., Koushik, Anita, Mayrand, Marie Hélène, Villa, Luisa L., Franco, Eduardo L.
Publicado no PLoS One (2016)

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

Por Tota, Joseph E., Struyf, Frank, Merikukka, Marko, Gonzalez, Paula, Kreimer, Aimée R., Bi, Dan, Castellsagué, Xavier, de Carvalho, Newton S., Garland, Suzanne M., Harper, Diane M., Karkada, Naveen, Peters, Klaus, Pope, Willy A. J., Porras, Carolina, Quint, Wim, Rodriguez, Ana Cecilia, Schiffman, Mark, Schussler, John, Skinner, S. Rachel, Teixeira, Júlio Cesar, Wheeler, Cosette M., Herrero, Rolando, Hildesheim, Allan, Lehtinen, Matti
Publicado no J Natl Cancer Inst (2017)